Attilio Olivieri - Concepedia

Author

Attilio Olivieri

Also Known As

A O Olivieri, A OLIVIERI, A Olivieri, A. OLIVIERI, A. Olivieri, Attilio OLIVIERI, Attilio Olivieri, Kazimierz Halaburda, Olivieri A, Olivieri, Attilio

355

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Ospedali Riuniti di Ancona Marche Polytechnic University Istituti di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico San Martino Azienda Ospedaliero Universitaria Ospedali Riuniti

About

Attilio Olivieri is an author at Ospedali Riuniti di Ancona specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	42	1.9K
2	Health Sciences	15	19	843
3	Blood Transplantation	12	12	342
4	Cell Biology	8	8	469
5	Biochemistry	1	1	85

Attilio Olivieri

100

Publications

Citations

H-Index

Page 1

	Year	Citations
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, The Lancet Haematology	2020	551
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report Stephanie J. Lee, Daniel Wolff, Carrie L. Kitko, Biology of Blood and Marrow Transplantation	2015	402
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage Marco Ladetto, Federica De Marco, Fabio Benedetti, Blood	2008	253
Imatinib for refractory chronic graft-versus-host disease with fibrotic features Attilio Olivieri, Franco Locatelli, Marco Zecca, Blood	2009	231
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease Silvia Svegliati, Attilio Olivieri, Nadia Campelli, Blood	2007	215
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. Gino Santini, Luigi Salvagno, Pietro Leoni, Journal of Clinical Oncology	1998	207
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) Corrado Girmenia, Anna Maria Raiola, Alfonso Piciocchi, Biology of Blood and Marrow Transplantation	2014	174
Treatment of refractory chronic GVHD with rituximab: a GITMO study Francesco Zaja, Andrea Bacigalupo, Francesca Patriarca, Bone Marrow Transplantation ImmunologyTreatment OptionPharmacotherapyRefractory Chronic GvhdMedicine	2007	169
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies Paolo Corradini, Corrado Tarella, Attilio Olivieri, Blood	2002	156
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi, Clinical Infectious Diseases	2017	151

Page 1